AI & ChatGPT searches , social queriess for SARS COV-2-LAMBDA-VARIANT
Search references for SARS COV-2-LAMBDA-VARIANT. Phrases containing SARS COV-2-LAMBDA-VARIANT
See searches and references containing SARS COV-2-LAMBDA-VARIANT!
Search references for SARS COV-2-LAMBDA-VARIANT. Phrases containing SARS COV-2-LAMBDA-VARIANT
See searches and references containing SARS COV-2-LAMBDA-VARIANT!SARS COV-2-LAMBDA-VARIANT
Variant of SARS-CoV-2
The Lambda variant, also known as lineage C.37, is a variant of SARS-CoV-2, the virus that causes COVID-19. It was first detected in Peru in August 2020
SARS-CoV-2_Lambda_variant
Variant of the SARS-Cov-2 virus
Zeta variant, also known as lineage P.2, is a variant of SARS-CoV-2, the virus that causes COVID-19. It was first detected in the state of Rio de Janeiro;
SARS-CoV-2_Zeta_variant
Variant of SARS-CoV-2 detected late 2020
variant (B.1.617.2) was a variant of SARS-CoV-2, the virus that causes COVID-19. It was first detected in India on 5 October 2020. The Delta variant was
SARS-CoV-2_Delta_variant
Virus that causes COVID-19
(SARSr-CoV), as is SARS-CoV-1, the virus that caused the 2002–2004 SARS outbreak. Some animal-borne coronaviruses are more closely related to SARS-CoV-2 than
SARS-CoV-2
Variant of the SARS-Cov-2 virus
The Eta variant is a variant of SARS-CoV-2, the virus that causes COVID-19. The Eta variant or lineage B.1.525, also called VUI-21FEB-03 (previously VUI-202102/03)
SARS-CoV-2_Eta_variant
Variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are viruses that, while similar to the original, have genetic changes that are
Variants_of_SARS-CoV-2
Variant of the SARS-CoV-2 virus
The Theta variant (P.3) was a SARS-CoV-2 variant of interest. It was first detected in the Philippines through genomic surveillance in early 2021, with
SARS-CoV-2_Theta_variant
Omicron subvariant of SARS-CoV-2
BA.3.2 is a heavily mutated Omicron subvariant of SARS-CoV-2, the virus that causes COVID-19. The variant was descended from an ancestral version of Omicron
BA.3.2
Variant of SARS-CoV-2, the virus that causes COVID-19
The Alpha variant (B.1.1.7) was a SARS-CoV-2 variant of concern. It was estimated to be 40–80% more transmissible than the wild-type SARS-CoV-2 (with most
SARS-CoV-2_Alpha_variant
Variant of the virus SARS-CoV-2
The Gamma variant (P.1) was one of the variants of SARS-CoV-2, the virus that causes COVID-19. This variant of SARS-CoV-2 has been named lineage P.1 and
SARS-CoV-2_Gamma_variant
Variant of the SARS-Cov-2 virus first identified in New York City
Iota variant, also known as lineage B.1.526, is one of the variants of SARS-CoV-2, the virus that causes COVID-19. It was first detected in New York City
SARS-CoV-2_Iota_variant
Variant of the SARS-CoV-2 virus
The Mu variant (B.1.621) is a variant of SARS-CoV-2. It was first detected in Colombia in January 2021 and was classified by the World Health Organization
SARS-CoV-2_Mu_variant
Variant of the SARS-Cov-2 virus
Epsilon variant, also known as CAL.20C and referring to two PANGO lineages B.1.427 and B.1.429, is one of the variants of SARS-CoV-2, the virus that causes
SARS-CoV-2_Epsilon_variant
Topics referred to by the same term
Canada Lambda (anatomy), a point on the skull Lambda (unit), a non-SI unit of volume Lambda baryon, a family of subatomic particles SARS-CoV-2 Lambda variant
Lambda_(disambiguation)
Inquiries into the origins of SARS-CoV-2
introducing SARS-CoV-2 to humans likely occurred in late 2019. As with the 2002–2004 SARS-CoV-1 outbreak, efforts to trace the origins of SARS-CoV-2 have spanned
Origin_of_SARS-CoV-2
Variant of the SARS-CoV-2 virus
The Beta variant (B.1.351) was a variant of SARS-CoV-2, the virus that causes COVID-19. One of several SARS-CoV-2 variants initially believed to be of
SARS-CoV-2_Beta_variant
Type of coronavirus detected in 2021
Omicron (B.1.1.529) is a heavily mutated variant of SARS-CoV-2 first reported to the World Health Organization (WHO) by the Network for Genomics Surveillance
SARS-CoV-2_Omicron_variant
Type of the virus detected in 2020
Kappa variant is a variant of SARS-CoV-2, the virus that causes COVID-19. It is one of the three sublineages of Pango lineage B.1.617. The SARS-CoV-2 Kappa
SARS-CoV-2_Kappa_variant
Omicron subvariant of SARS-CoV-2
BA.2.86 is a heavily-mutated Omicron subvariant of SARS-CoV-2, the virus that causes COVID-19. BA.2.86 is notable for having more than thirty mutations
BA.2.86
showed that 40% of sampled white-tailed deer demonstrated evidence of SARS-CoV-2 antibodies, with the highest percentages in Michigan, at 67%, and Pennsylvania
SARS-CoV-2 in white-tailed deer
SARS-CoV-2_in_white-tailed_deer
Mechanisms that spread coronavirus disease 2019
"The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus". Journal of Travel Medicine. 28
Transmission_of_COVID-19
Long-term complication of COVID-19
problems persisting or developing after an initial period of COVID‑19 from SARS-CoV-2 infection. Symptoms can last weeks, months, or years and are often debilitating
Long_COVID
Contagious disease caused by SARS-CoV-2
disease 2019 (COVID-19) is a contagious disease caused by the coronavirus SARS-CoV-2. Starting in January 2020, the disease spread worldwide, resulting in
COVID-19
has an expanded host range compared to SARS-CoV-1 and MERS-CoV. SARS-CoV-2 (along with SARS-CoV-1 and MERS-CoV) are generalist viruses, not specifically
Zoonotic_origins_of_COVID-19
Pandemic caused by SARS-CoV-2
pandemic), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), began with an outbreak in Wuhan, China, in December 2019. It spread
COVID-19_pandemic
Topics referred to by the same term
a chess opening Route C37 (Massachusetts), a street in Boston SARS-CoV-2 Lambda variant, also known as lineage C.37 This disambiguation page lists articles
C37
Script used to write the Greek language
discontinued. In May 2021 the World Health Organization announced that the variants of SARS-CoV-2 of the virus would be named using letters of the Greek alphabet
Greek_alphabet
American mink and European mink have shown high susceptibility to the SARS-CoV-2 virus since the earliest stages of the COVID-19 pandemic, first in mink
SARS-CoV-2_in_mink
Vaccine against COVID-19
COVID‑19 caused by SARS-CoV-2. In the US, Nuvaxovid is indicated for active immunization to prevent COVID‑19 caused by SARS-CoV-2 in adults aged 65 years
Novavax_COVID-19_vaccine
This article documents the chronology and epidemiology of SARS-CoV-2 in December 2020, the virus which causes the coronavirus disease 2019 (COVID-19) and
Timeline of the COVID-19 pandemic in December 2020
Timeline_of_the_COVID-19_pandemic_in_December_2020
Aspect of viral disease pandemic
This article documents the chronology and epidemiology of SARS-CoV-2 in January 2021, the virus which causes the coronavirus disease 2019 (COVID-19) and
Timeline of the COVID-19 pandemic in January 2021
Timeline_of_the_COVID-19_pandemic_in_January_2021
Vaccine against SARS-CoV-2
A COVID‑19 vaccine is designed to induce immunity against SARS-CoV-2, the virus responsible for coronavirus disease 2019 (COVID-19). COVID-19 vaccines
COVID-19_vaccine
Chronology and epidemiology of SARS-CoV-2
COVID-19 pandemic, involving coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2, in 2023. The WHO ended the public health emergency of international concern
Timeline of the COVID-19 pandemic in 2023
Timeline_of_the_COVID-19_pandemic_in_2023
Variant of the SARS-CoV-2 virus
Serum Institut for a virus variant described by the institute in autumn 2020, in connection with investigations of SARS-CoV-2 infection among mink and humans
Cluster_5
Topics referred to by the same term
illusion relating to the human perception of time SARS-CoV-2 Kappa variant, one of the variants of SARS-CoV-2, the virus that causes COVID-19 Honda Capa, a
Kappa_(disambiguation)
Vaccine against COVID-19
that is similar to the inactivated polio vaccine. Initially, a sample of SARS-CoV-2 was isolated by India's National Institute of Virology and used to grow
Covaxin
Clinical research to establish the characteristics of COVID-19 vaccines
2020, a new SARS‑CoV‑2 variant, the Alpha variant or lineage B.1.1.7, was identified in the UK. Early results suggest protection to the variant from the
COVID-19 vaccine clinical research
COVID-19_vaccine_clinical_research
Type of vaccine for humans
glycoprotein of SARS-CoV-2 Wuhan-Hu-1 strain (Original)" and 15 mcg "of modRNA encoding the S glycoprotein of SARS-CoV-2 Omicron variant lineages BA.4 and
Pfizer–BioNTech COVID-19 vaccine
Pfizer–BioNTech_COVID-19_vaccine
Vaccine candidate against COVID-19
ReCOV is a COVID-19 vaccine candidate developed by Jiangsu Rec-Biotechnology Co Ltd. Clinical trial number NCT04818801 for "Safety, Reactogenicity and
ReCOV
This article documents the chronology and epidemiology of SARS-CoV-2, the virus that causes the coronavirus disease 2019 (COVID-19) and is responsible
Timeline of the COVID-19 pandemic in September 2021
Timeline_of_the_COVID-19_pandemic_in_September_2021
Vaccine candidate against COVID-19
and day 51 (intranasal spray). Razi Cov Pars is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike protein. It's planned to produce
Razi_Cov_Pars
Viral vector vaccine for prevention of COVID-19
(2021). "Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo". Nature Communications. 12 (1) 6220.
Oxford–AstraZeneca COVID-19 vaccine
Oxford–AstraZeneca_COVID-19_vaccine
contacts Zhan Y, Yin H, Yin JY (14 February 2022). "B.1.617.2 (Delta) Variant of SARS-CoV-2: features, transmission and potential strategies". Int J Biol
Symptoms_of_COVID-19
hypotheses: The direct route of transplacental transmission. Like SARS-CoV, SARS-CoV-2 might create its entry point into the brain through the ACE2 receptor
COVID-19_in_pregnancy
Misinformation regarding the SARS-CoV-2 vaccine and the resulting hesitancy towards it
of laboratory rodents with vaccines for SARS-CoV, the virus that causes severe acute respiratory syndrome (SARS). However, as of 27 January 2022[update]
COVID-19 vaccine misinformation and hesitancy
COVID-19_vaccine_misinformation_and_hesitancy
Vaccine candidate against COVID-19
or Variant-Matched Bivalent V-01D-351 Booster following Primary Series of Inactivated Vaccine Enhances the Neutralizing Capacity against SARS-CoV-2 Delta
V-01
Aspect of viral disease pandemic
This article documents the chronology and epidemiology of SARS-CoV-2 in 2019, the virus that causes coronavirus disease 2019 (COVID-19) and is responsible
Timeline of the COVID-19 pandemic in 2019
Timeline_of_the_COVID-19_pandemic_in_2019
Vaccine against COVID-19
Covaxin, other inactivated virus vaccines for COVID-19. Its product name is SARS-CoV-2 Vaccine (Vero Cell), not to be confused with the similar product name
Sinopharm BIBP COVID-19 vaccine
Sinopharm_BIBP_COVID-19_vaccine
Vaccine against COVID-19
known as the Sinovac COVID-19 vaccine, was a whole inactivated virus SARS-CoV-2 vaccine developed by Sinovac and extensively deployed globally to control
CoronaVac
Vaccine candidate against COVID-19
DNA plasmid vector that carries the gene encoding the spike protein of SARS-CoV-2. As with other DNA vaccines, the recipient's cells then produce the spike
ZyCoV-D
Fifteenth letter of the Greek alphabet
describe variants of concern of SARS‑CoV‑2, the virus which causes COVID-19. On November 26, 2021, Omicron was assigned to the B.1.1.529 variant of concern
Omicron
This article documents the chronology and epidemiology of SARS-CoV-2, the virus that causes the coronavirus disease 2019 (COVID-19) and is responsible
Timeline of the COVID-19 pandemic in April 2021
Timeline_of_the_COVID-19_pandemic_in_April_2021
Diagnostic testing for SARS-CoV-2 virus infection
involves analyzing samples to assess the current or past presence of SARS-CoV-2, the virus that causes COVID-19 and is responsible for the COVID-19 pandemic
COVID-19_testing
COVID-19 elimination strategy
cold, achieving the complete elimination of a respiratory virus like SARS-CoV-2 may not have been a realistic goal. To achieve zero-COVID in an area with
Zero-COVID
This article documents the chronology and epidemiology of SARS-CoV-2, the virus that causes the coronavirus disease 2019 (COVID-19) and is responsible
Timeline of the COVID-19 pandemic in July 2021
Timeline_of_the_COVID-19_pandemic_in_July_2021
Russian vaccine against COVID-19
full-length spike protein (S) of SARS-CoV-2 to stimulate an immune response. Adenoviral vectors for expression of the SARS-CoV-2 spike protein have also been
Sputnik_V_COVID-19_vaccine
diets for atherosclerosis prevention. 7 July A preprint finds the SARS-CoV-2 Delta variant to cause a ~108 % increased – or more than twice as large – risk
2021_in_science
Vaccine candidate against COVID-19
SARS-CoV-2 Spike Protein Vaccine (CHO Cell)" at ClinicalTrials.gov Clinical trial number NCT04990544 for "Phase II Clinical Trial of Recombinant SARS-CoV-2
202-CoV
Scientific work to develop a vaccine for COVID-19
SARS-CoV-2, the virus that causes COVID-19, was isolated in late 2019. Its genetic sequence was published on 11 January 2020, setting off an intense research
History of COVID-19 vaccine development
History_of_COVID-19_vaccine_development
Protein subunit vaccine against COVID-19
vaccine consists of a version of the receptor binding domain (RBD) of the SARS‑CoV‑2 spike protein, together with the adjuvants aluminium hydroxide gel and
Corbevax
Fourth letter in the Greek alphabet
mathematics, science, and engineering ∇ – Nabla symbol Delta Air Lines SARS-CoV-2 Delta variant "delta". Oxford English Dictionary (online ed.). Oxford University
Delta_(letter)
Restrictions by countries intended to stop spread of disease
"China's neighbors close borders as country's coronavirus cases surpass SARS". Newsweek. Archived from the original on 9 February 2020. Retrieved 10 February
Travel during the COVID-19 pandemic
Travel_during_the_COVID-19_pandemic
Impact of COVID-19
other key infrastructure elements necessary to mitigate the spread of SARS-CoV-2. To help reduce demand during peak hours, the Akamai content delivery
Impact of the COVID-19 pandemic on the video game industry
Impact_of_the_COVID-19_pandemic_on_the_video_game_industry
This article documents the chronology and epidemiology of SARS-CoV-2, the virus that causes the coronavirus disease 2019 (COVID-19) and is responsible
Timeline of the COVID-19 pandemic in May 2022
Timeline_of_the_COVID-19_pandemic_in_May_2022
inhalation of respiratory droplets or aerosol particles contaminated with SARS-CoV-2. The viral deposition occurs on mucous membranes of nose, mouth, or eyes
Development_of_COVID-19_tests
Health control procedure against COVID-19
as public and personal health control measures against the spread of SARS-CoV-2, the virus that causes COVID-19. In community and healthcare settings
Face masks during the COVID-19 pandemic
Face_masks_during_the_COVID-19_pandemic
The COVID-19 pandemic has affected animals directly and indirectly. SARS-CoV-2, the virus that causes COVID-19, is zoonotic, which likely to have originated
COVID-19_pandemic_and_animals
This article documents the chronology and epidemiology of SARS-CoV-2, the virus that causes the coronavirus disease 2019 (COVID-19) and is responsible
Timeline of the COVID-19 pandemic in December 2021
Timeline_of_the_COVID-19_pandemic_in_December_2021
Protein subunit vaccine against COVID-19
against SARS‑CoV‑2 virus in order to prevent COVID‑19. The Sanofi–GSK COVID‑19 vaccine is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike
Sanofi–GSK_COVID-19_vaccine
RNA COVID-19 vaccine
provides protection against COVID-19, which is caused by infection by the SARS-CoV-2 virus. A different version of the Moderna COVID-19 vaccine, sold under
Moderna_COVID-19_vaccine
This article documents the chronology and epidemiology of SARS-CoV-2, the virus that causes the coronavirus disease 2019 (COVID-19) and is responsible
Timeline of the COVID-19 pandemic in October 2021
Timeline_of_the_COVID-19_pandemic_in_October_2021
False or misleading virus information
of SARS-CoV-2 has resulted in a health crisis not witnessed since the 1918–19 Spanish influenza pandemic. The most plausible origin of SARS-CoV-2 is natural
COVID-19_misinformation
concerns. These symptoms result from multiple different factors. SARS-Coronavirus-2 (SARS-CoV-2) directly infects olfactory neurons (smell) and nerve cells
Impact of COVID-19 on neurological, psychological and other mental health outcomes
Impact_of_COVID-19_on_neurological,_psychological_and_other_mental_health_outcomes
Prevention measures for COVID-19
(July 2022). "Association of Omicron vs Wild-type SARS-CoV-2 Variants With Hospital-Onset SARS-CoV-2 Infections in a US Regional Hospital System". Jama
Workplace hazard controls for COVID-19
Workplace_hazard_controls_for_COVID-19
communicate with the report author. On 8 January 2020, a new coronavirus (SARS-CoV-2) was announced by Chinese scientists as the cause of the new disease;
Chinese government response to COVID-19
Chinese_government_response_to_COVID-19
Vaccine against COVID-19
been modified to contain the gene for making the spike protein of the SARS-CoV-2 virus that causes COVID‑19. The body's immune system responds to this
Janssen_COVID-19_vaccine
Type of vaccine
respiratory syncytial virus, HIV, and malaria, before the vaccines that target SARS-CoV-2, which causes COVID-19. Two Ebola vaccines that used viral vector technology
Viral_vector_vaccine
Chronology and epidemiology of SARS-CoV-2
This article documents the chronology and epidemiology of SARS-CoV-2, the virus that causes the coronavirus disease 2019 (COVID-19) and is responsible
Timeline of the COVID-19 pandemic in September 2022
Timeline_of_the_COVID-19_pandemic_in_September_2022
Vaccine against COVID-19
strain of SARS-COV-2 as well as variants that were present in Cuba during the study, including Alpha, Beta, and Gamma strains. The Beta variant entered
Abdala_(vaccine)
This article documents the chronology and epidemiology of SARS-CoV-2, the virus that causes the coronavirus disease 2019 (COVID-19) and is responsible
Timeline of the COVID-19 pandemic in July 2022
Timeline_of_the_COVID-19_pandemic_in_July_2022
were a proof of vaccination requirement for attendees. However, Omicron variant would begin to lead to the cancellations of other events, including the
Impact of the COVID-19 pandemic on sports
Impact_of_the_COVID-19_pandemic_on_sports
Plan to immunize against COVID-19 in South Africa
immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response
COVID-19 vaccination in South Africa
COVID-19_vaccination_in_South_Africa
This article documents the chronology and epidemiology of SARS-CoV-2, the virus that causes the coronavirus disease 2019 (COVID-19) and is responsible
Timeline of the COVID-19 pandemic in March 2021
Timeline_of_the_COVID-19_pandemic_in_March_2021
Topics referred to by the same term
structure Beta-endorphin, a kind of neurotransmitter SARS-CoV-2 Beta variant, one of the variants of SARS-CoV-2, the virus that causes COVID-19 Beta (plasma physics)
Beta_(disambiguation)
Vaccine candidate against COVID-19
B vaccine and Pertussis vaccine. SCB-2019 has a trimeric form of the SARS-CoV-2 spike protein (S-Trimer) combined with one of two different adjuvants
SCB-2019
Drug repurposing research related to COVID-19
and the general replication kinetics and the biology of the MERS, SARS and [SARS-CoV-2] viruses are very similar, so testing drugs which target relatively
COVID-19 drug repurposing research
COVID-19_drug_repurposing_research
Vaccine candidate against COVID-19
assess the safety and immunogenicity of Anti-COVID-19 AKS-452 vaccine for SARS-Cov-2 infection in Indian healthy subjects". ctri.nic.in. 11 October 2021. CTRI/2021/10/037269
AKS-452
Chronology and epidemiology of SARS-CoV-2
This article documents the chronology and epidemiology of SARS-CoV-2, the virus that causes the coronavirus disease 2019 (COVID-19) and is responsible
Timeline of the COVID-19 pandemic in December 2022
Timeline_of_the_COVID-19_pandemic_in_December_2022
Vaccine against COVID-19
of ZF2001-elicited antisera to SARS-CoV-2 variants". The Lancet. Microbe. 2 (10): e494. doi:10.1016/S2666-5247(21)00217-2. PMC 8378832. PMID 34458880. S2CID 237246788
ZF2001
Vaccine candidate against COVID-19
sequences from the spike, nucleocapsid, and membrane proteins of SARS-CoV-1 and SARS-CoV-2. It also contains a proprietary UBITh1 peptide derived from the
UB-612
Sequence of major events in a virus pandemic
for the Christmas holidays in order to combat the spread of the SARS-CoV-2 Omicron variant. Mayor of New York City Bill de Blasio has announced that all
Responses to the COVID-19 pandemic in December 2021
Responses_to_the_COVID-19_pandemic_in_December_2021
Preventative and therapeutic medications for COVID-19 infection
2, known as SARS-CoV-2. It was developed by GlaxoSmithKline and Vir Biotechnology, Inc. Sotrovimab is designed to attach to the spike protein of SARS-CoV-2
COVID-19_drug_development
Vaccine against COVID-19
Safety, Tolerability and Immunogenicity of an Inactiviated Adjuvanted Sars-Cov-2 Virus Vaccine Candidate Against Covid-19 in Healthy Adults" at ClinicalTrials
Valneva_COVID-19_vaccine
time; he is the first star player known to be diagnosed with the Delta variant. At about the same time, Indianapolis Colts head coach Frank Reich tested
Impact of the COVID-19 pandemic on gridiron football
Impact_of_the_COVID-19_pandemic_on_gridiron_football
Vaccine against COVID-19
study of the effectiveness of two Russian vaccines against the SARS-CoV-2 Delta variant in Moscow (June–July 2021) proved that EpiVacCorona, unlike Sputnik
EpiVacCorona
This article documents the chronology and epidemiology of SARS-CoV-2, the virus that causes the coronavirus disease 2019 (COVID-19) and is responsible
Timeline of the COVID-19 pandemic in August 2021
Timeline_of_the_COVID-19_pandemic_in_August_2021
Vaccine candidate against COVID-19
by Nanogen Pharmaceutical Biotechnology JSC. It is a subunit vaccine (SARS‑CoV‑2 recombinant spike protein with aluminum adjuvant). The vaccine requires
Nanocovax
This article documents the chronology and epidemiology of SARS-CoV-2, the virus that causes the coronavirus disease 2019 (COVID-19) and is responsible
Timeline of the COVID-19 pandemic in May 2021
Timeline_of_the_COVID-19_pandemic_in_May_2021
Impact of COVID-19
closed. On 29 June, due to the rapidly increasing incidence of the Delta variant, the government announced that the planned reopening of indoor dining and
Impact of the COVID-19 pandemic on the food industry
Impact_of_the_COVID-19_pandemic_on_the_food_industry
This article documents the chronology and epidemiology of SARS-CoV-2, the virus that causes the coronavirus disease 2019 (COVID-19) and is responsible
Timeline of the COVID-19 pandemic in February 2021
Timeline_of_the_COVID-19_pandemic_in_February_2021
SARS COV-2-LAMBDA-VARIANT
SARS COV-2-LAMBDA-VARIANT
Female
Finnish
Finnish form of Hebrew Sarah, SARI means "noble lady, princess."
Surname or Lastname
English
English : variant of Marsh.French : habitational name from places so named in Ardèche, Ardennes, Gard, Loire, Nièvre, and Meurthe-et-Moselle, from the Latin personal name Marcius, used adjectivally.French : from the personal name Meard, Mard, Mart, vernacular forms of the saint’s name Médard. Morlet notes that there are a number of places called Saint-Mars, formerly recorded in Latin as Sanctus Medardus.French : from the name of the month, mars ‘ March’, denoting seed sown in March, and hence a metonymic name for an arable grower.French (De Mars) : habitational name from Mars in the Ardennes.Dutch : from a short form of the personal name Marsilius.
Surname or Lastname
English
English : from a pet form of Lamb 1 and 2.English : from an Old Norse personal name Lambi, from lamb ‘lamb’.
Male
Spanish
Medieval form of Spanish Sancho, SANS means "holy."
Female
Spanish
Feminine form of Spanish Amado, AMADA means "beloved."
Surname or Lastname
English
English : habitational name from Lambden in Berwickshire.
Female
English
Anglicized form of Greek Sarra, SARA means "noble lady, princess."Â In the bible, this is the name that God gave to Sarai, wife of Abraham. This form of the name is in wide use throughout Europe: Dutch, German, Greek, Italian, Polish, Portuguese, Spanish, Scandinavian, and Slovene.
Female
Italian
Italian form of English Amber, AMBRA means "amber."
Girl/Female
Arabic, Indian, Muslim, Pashtun, Sanskrit
Flame; Large; Spacious; Tall; Another Name for Durga and Lakshmi
Male
French
French and Spanish form of Roman Latin Cæsar, CÉSAR means "severed."
Female
Native American
Native American Indian name ALAMEDA means "grove of cottonwood."
Surname or Lastname
Irish
Irish : reduced form of McCoy.English : nickname for a quiet and unassuming person, from Middle English, Old French coi, quei ‘calm’, ‘quiet’ (Latin quietus).
Girl/Female
Indian
Flame
Surname or Lastname
English
English : from Cocke in any the senses described + the suffix -s denoting ‘son of’ or ‘servant of’.Irish (Ulster) : mistranslation of Mac Con Coille (‘son of Cú Choille’, a personal name meaning ‘hound of the wood’), as if formed with coileach ‘cock’, ‘rooster’.
Male
Scandinavian
Scandinavian form of Icelandic Lárus, LARS means "laurel."
Surname or Lastname
English
English : habitational name from a place named Cove, examples of which are found in Devon, Hampshire, and Suffolk, from Old English cofa ‘cove’, ‘bay’, ‘inlet’, also ‘shelter’, ‘hut’, or a topographic name with the same meaning.
Surname or Lastname
Irish (Kerry)
Irish (Kerry) : Anglicized form of Gaelic Mac Saoghair, which in turn may be a patronymic from a Gaelicized form of the Old English personal name Saeger (see 2 below).English : patronymic from a Middle English personal name Saher or Seir (see Sayer 1).Americanized form of French Cyr.Richard Sears came to Plymouth, MA, from England about 1630.
Girl/Female
Muslim
Flame
Surname or Lastname
Variant of Nicolai 2.English
Variant of Nicolai 2.English : variant of Nicholas.
Male
Hebrew
(דּï‹×‘) Hebrew name DOV means "bear."
SARS COV-2-LAMBDA-VARIANT
SARS COV-2-LAMBDA-VARIANT
Female
English
English variant spelling of Latin Lavinia, possibly LUVINIA means "purity."Â
Boy/Male
Hindu
Perceive or vision or paying respect or religious text
Girl/Female
Hindu
Sky
Girl/Female
Tamil
Liberated, Pearl
Boy/Male
Tamil
Temple
Boy/Male
Biblical
Order, succession, mountainous.
Boy/Male
Greek Polish
Lordly.
Boy/Male
Irish
Twin.
Girl/Female
African, Arabic, British, Christian, Danish, English, French, German, Hindu, Indian, Kannada, Lebanese, Marathi, Muslim, Parsi, Punjabi, Sikh, Swahili
Beautiful
Girl/Female
Biblical
City of letters, or of the book.
SARS COV-2-LAMBDA-VARIANT
SARS COV-2-LAMBDA-VARIANT
SARS COV-2-LAMBDA-VARIANT
SARS COV-2-LAMBDA-VARIANT
SARS COV-2-LAMBDA-VARIANT
n.
Extreme republican principles; the principles or practice of the sans-culottes.
v. t.
To take the spars, stakes, or bars from.
v. t.
To furnish with a cog or cogs.
v. t.
To sift through a sarse.
a.
Pertaining to, or involving, sans-culottism; radical; revolutionary; Jacobinical.
n.
A viola da gamba.
n.
The point of junction of the sagittal and lambdoid sutures of the skull.
n.
The metallic element iron, the symbol of which / was the same as that of the planet Mars.
v. i.
To bring forth a lamb or lambs, as sheep.
imp. & p. p.
of Lamb
n.
A cover or sheath; as, a roller cot (the clothing of a drawing roller in a spinning frame); a cot for a sore finger.
n.
A hydrocarbon radical, CH2.(CO)2, from malonic acid.
a.
In the direction toward which stars appear to move. See Following, 2.
n.
The name of the Greek letter /, /, corresponding with the English letter L, l.
a.
Haughty; purse-proud. See Cob, n., 2.